Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

ClinicalTrials.gov ID: NCT04921969

Public ClinicalTrials.gov record NCT04921969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Children (Ages≥ 2 Years to < 12 Years) With Atopic Dermatitis ((TRuE-AD3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study. Participants will be randomized 2:2:1 to blinded treatment with ruxolitinib cream 0.75% ,1.5% , or vehicle cream, with stratification by baseline IGA score and age. At Week 8, efficacy will be evaluated. Participants who complete Week 8 assessments with no additional safety concerns will continue into the 44-week Long Term Safety (LTS) period with the same treatment regimen, except those initially randomized to vehicle cream will be rerandomized (1:1) in a blinded manner to 1 of the 2 active treatment groups (ruxolitinib cream 0.75% or 1.5%).

Study identification

NCT ID
NCT04921969
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
330 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 19, 2021 (Actual)
Primary completion
May 10, 2023 (Actual)
Completion
Apr 8, 2024 (Actual)
Last update posted
Mar 28, 2025

2021 – 2024

United States locations

U.S. sites
64
U.S. states
27
U.S. cities
52
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209 —
Cahaba Dermatology Hoover Alabama 35244 —
Physicians Research Group Ii Gilbert Arizona 85295 —
Cct Research With Center For Dermatology and Plastic Surgery Scottsdale Arizona 85260 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
First Oc Dermatology Fountain Valley California 92708 —
Iact Health Los Angeles California 90017 —
Metropolis Dermatology Los Angeles California 90017 —
University of Southern California Los Angeles California 90033 —
Dermatology Research Associates Los Angeles California 90045 —
Madera Family Medical Group Madera California 93637 —
Allergy & Asthma Associates of Southern California Mission Viejo California 92691 —
Palmtree Clinical Research-Clinedge-Ppds Palm Springs California 92262 —
Integrated Research of Inland, Inc Riverside California 92506 —
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404 —
Phdermatology Clearwater Florida 33756 —
Life Clinical Trials Margate Margate Florida 33063 —
Acevedo Clinical Research Miami Florida 33142 —
Pediatric Center of Excellence Pce Miami Pediatric Endocrinology, Llc Miami Florida 33146 —
The Childrens Skin Center Csc Miami Miami Florida 33155 —
Entrust Clinical Research Miami Florida 33156 —
Ciocca Dermatology Pa Miami Florida 33173 —
Forcare Clinical Research Tampa Florida 33624 —
Aeroallergy Research Lab of Savannah Savannah Georgia 31406 —
Northwestern Memorial Hospital-Arkes Pavilion Chicago Illinois 60611 —
Sneeze Wheeze and Itch Associates Llc Normal Illinois 61761 —
Northshore Medical Group Dermatology Skokie Skokie Illinois 60076 —
Dermatology Specialists Research Indiana Clarksville Indiana 47129 —
Dawes Fretzin Clinical Research Group Llc Indianapolis Indiana 46250 —
Kansas City Dermatology P.A. Lenexa Kansas 66215 —
Office of Michael W. Simon, Md Nicholasville Kentucky 40356 —
Meridian Clinical Research Baton Rouge Louisiana 70808 —
Delricht Clinical Research-Clinedge-Ppds Baton Rouge Baton Rouge Louisiana 70809 —
Delricht Research-Touro Medical Center New Orleans Louisiana 70115 —
Lawrence J. Green, Md. Llc Rockville Maryland 20850 —
Henry Ford Medical Center-New Center One Detroit Michigan 48202 —
Michigan Dermatology Institute Waterford Michigan 48328 —
Mayo Clinic Rochester Minnesota 55905 —
Skin Specialists Pc the Advanced Skin Research Center Omaha Nebraska 68144 —
Dr Bobby Buka, Md Greenwich Village New York New York 10012 —
New York University Langone Medical Center-Fink Children'S Ambulatory Care Center New York New York 10016 —
Ohio Pediatric Research Association Dayton Ohio 45414 —
Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc Grants Pass Oregon 97527 —
Cyn3Rgy Research-Clinedge-Ppds Gresham Oregon 97030 —
Velocity Clinical Research-Medford Medford Oregon 97504 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Knight Cancer Institute At Oregon Health and Science University Portland Oregon 97239 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Rhode Island Hospital Providence Rhode Island 02903 —
Coastal Pediatric Associates Charleston South Carolina 29414 —
Medical University of South Carolina Charleston South Carolina 29425 —
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130 —
Arlington Research Center Arlington Texas 76011 —
Progressive Clinical Research San Antonio Texas 78213 —
Texas Dermatology Alamo Heights Office San Antonio Texas 78218 —
Allergy and Asthma Care of Waco, Pa Waco Texas 76712 —
Intermountain Clinical Research Icr Draper Draper Utah 84020 —
Springville Dermatology Springville Utah 84663 —
Jordan Valley Dermatology Center West Jordan Utah 84088 —
Skindc Clinic Arlington Virginia 22209 —
Pi Coor Clinical Research Llc Burke Virginia 22015 —
Clinical Research Partners Llc Richmond Virginia 23220 —
Dermatology Specialists of Spokane Spokane Washington 99202 —
Children'S Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04921969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2025 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04921969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →